IN THEIR FIGHT AGAINST THE PANDEMIC, federal officials are boosting the fortunes of some little-known or emerging in vitro diagnostics (IVD) companies. One example is the recent award of a $481 million  COVID-19 test contract to Cue Health Inc., of San Diego. Earlier this month, the federal Department of Health and Human Services (HHS) and the Department of Defense (DoD) announced a contract that […]
- IVD Update
$481 Mil Federal COVID Contract Awarded to Young IVD Company
HHS had relationship since 2018 with Cue Health; wants to quickly scale up made-in-USA portable tests
- By Robert Michel
- > From the Volume XXVII, No. 15 - October 26, 2020 Issue
- Tags: clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, COVID-19 Molecular Testing, COVID-19 Rapid Testing, COVID-19 test, covid-19 testing, COVID-19 tests, ivd/lab informatics, lab test, lab testing, lab tests, laboratory test, laboratory testing, laboratory tests, molecular point-of-care tests, rapid molecular COVID-19 tests
